|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1996-5-24
|
|
pubmed:abstractText |
Our purpose was to investigate the effects of hormone replacement therapy on the reactivity of monocytes and platelets in whole blood, measured by tissue factor activity, tumor necrosis factor-alpha, and thromboxane B2.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0002-9378
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
173
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1816-20
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8610768-Administration, Cutaneous,
pubmed-meshheading:8610768-Administration, Oral,
pubmed-meshheading:8610768-Adult,
pubmed-meshheading:8610768-Arteriosclerosis,
pubmed-meshheading:8610768-Blood Platelets,
pubmed-meshheading:8610768-Estradiol,
pubmed-meshheading:8610768-Estrogen Replacement Therapy,
pubmed-meshheading:8610768-Female,
pubmed-meshheading:8610768-Humans,
pubmed-meshheading:8610768-Medroxyprogesterone,
pubmed-meshheading:8610768-Middle Aged,
pubmed-meshheading:8610768-Monocytes,
pubmed-meshheading:8610768-Norethindrone,
pubmed-meshheading:8610768-Thromboplastin,
pubmed-meshheading:8610768-Thrombosis,
pubmed-meshheading:8610768-Thromboxane B2,
pubmed-meshheading:8610768-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Hormone replacement therapy reduces the reactivity of monocytes and platelets in whole blood--a beneficial effect on atherogenesis and thrombus formation?
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, University of Tromsø, Norway.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
